Guardion Health Sciences, Inc.
GHSIDelisted Oct 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001642375
Guardion Health Sciences, Inc. was delisted on Oct 11, 2024; its insiders filed their last Form 4 on Aug 28, 2024; 15 institutions reported holding it in 13F filings for Q3 2024, worth $587.7K in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 15
- Q3 2024, +4 vs. previous quarter
- 13F value
- $587.7K
- Reported value at the end of Q3 2024
- Superinvestors holding
- 0
- At the end of Q3 2024
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2023
- $12.2M
- +10.8% year over year
- Net income, FY2023
- $158.0K
- No comparable prior period
- Free cash flow, FY2023
- -$4.37M
- No comparable prior period
- Revenue, Q2 FY2024
- $72.9K
- −97.4% year over year
Revenue flow, FY2023
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net income for FY2023: $158.0K (1.3% of revenue).
Superinvestors holding GHSI, Q3 2024
Go to the superinvestors tabNo superinvestor reported holding GHSI at the end of Q3 2024.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Guardion Health Sciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 (view filing)4:11 PM ET | Aug 26 | 2 days | Radoff Bradley Louis and 1 other10% Owner | SSale | −105.5K | $14.10 | −$1.49M | −48.4%112.4K after | 3 lots |
| Aug 28, 2024 (view filing)4:11 PM ET | Aug 26 | 2 days | Radoff Bradley Louis and 1 other10% Owner | SSale | −10.1K | $13.80 | −$138.7K | −40.1%15.0K after | |
| Jan 11, 2023 (view filing)5:11 PM ET | Jan 9-10 | 2 days | Radoff Bradley Louis and 1 other10% Owner | PPurchase | +116.7K | $7.08 | +$825.8K | +115.4%217.9K after | 4 lots |
| Sep 1, 2021 (view filing) | Aug 30-31 | 2 days | Scholtes BretCEO and President | PPurchase | +10.0K | $1.24 | +$12.4K | +5.9%179.5K after | 2 lots |
| Aug 31, 2021 (view filing) | Aug 30 | 1 day | Gagliano Donald ADirector | PPurchase | +5.00K | $1.25 | +$6.25K | +22.0%27.8K after |
Top 10 13F holders, Q3 2024
See all 15 holdersThe largest institutional positions in Guardion Health Sciences, Inc. at the end of Q3 2024; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 38,804 | $215.0K | 0.00% | +1,884+5.1% | Added |
| UBS Group AG | 17,190 | $95.2K | 0.00% | +13,597+378.4% | Added |
| Vanguard Group Inc | 14,852 | $82.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 12,609 | $69.9K | 0.00% | +12,609 | New |
| HRT Financial LP | 11,579 | $64.0K | 0.00% | +11,579 | New |
| BlackRock, Inc. | 10,030 | $55.6K | 0.00% | +10,030 | New |
| Morgan Stanley | 559 | $3.10K | 0.00% | −100−15.2% | Reduced |
| Citigroup Inc | 373 | $2.07K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 50 | $277 | 0.00% | −712−93.4% | Reduced |
| Cornerstone Planning Group LLC | 37 | $122 | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of GHSI
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Guardion Health Sciences, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Great Point Capital LLC | 13G/A | 16.30% | – | May 23, 20241 filing | May 23, 2024 | SEC |